Clinical Trial Update: Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating long-term immunity of the Hantavax vaccine in people at high risk for hemorrhagic fever with renal syndrome has completed. The sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Fever with Renal Syndrome

Drugs mentioned

• Hantavax

Snippet

Sponsor: Green Cross Corporation | Conditions: Infection | Phase 3 | Status: COMPLETED